New River Pharmaceuticals (NRPH) Higher on Merger Chatter

New River Pharmaceuticals Inc. (Nasdaq: NRPH) is higher on talk the company may merge with UK specialty pharmaceutical company Shire plc (Nasdaq: SHPGY). The stock is 9% higher.

Shire Pharmaceutical (SHPGY) implied volatility below average at 27

Shire Pharmaceutical (Nasdaq: SHPGY): SHPGY a specialty pharmaceutical company closed at to $59.78. Dow Jones carried a story on 11/16/06 indicating AZN is mulling SHPGY takeover. SHPGY over all option implied volatility of 27 is below its 6-month average of 34 according to Track Data, suggesting decreasing price fluctuations. Paul Foster